SYRS - Syros Pharmaceuticals Inc. (SYRS) Q4 2023 Earnings Call Transcript
2024-03-27 10:40:24 ET
Syros Pharmaceuticals, Inc. (SYRS)
Q4 2023 Earnings Conference Call
March 27, 2024, 08:30 AM ET
Company Participants
Karen Hunady - Director of IR and Corporate Communications
Conley Chee - CEO
David Roth - CMO
Jason Haas - CFO
Conference Call Participants
Phil Nadeau - TD Cowen
Jason Butler - Citizens JMP
Presentation
Operator
Good morning and welcome to Syros Pharmaceuticals Fourth Quarter and Full Year 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode. This call is being webcast live on the Investors & Media section of Syros' website at www.syros.com. Please be advised that today's call is being recorded.
At this time, I would like to turn the call over to Karen Hunady, Director of Investor Relations and Corporate Communications at Syros.
Karen Hunady
Thank you. This morning, we issued a press release announcing our fourth quarter and full year 2023 financial results. The full release is available on the Investor & Media section of the Syros' website at www.syros.com....
Syros Pharmaceuticals, Inc. (SYRS) Q4 2023 Earnings Call Transcript